Search
Search
About
Log in
Join
Experiences with
Lymphocytic leukemia
Posts
Communities
3,085 public posts
Filter results
Agios and Alnylam sign agreement for siRNA candidate
« We are pleased to license this programme from Alnylam, the leading RNAi therapeutics company, with the goal of delivering a convenient, disease-modifying treatment option that addresses the underlying pathophysiology of PV and reduces or eliminates the need for phlebotomy. “We look forward to initiating
« We are pleased to license this programme from Alnylam, the leading RNAi therapeutics company, with the goal of delivering a convenient, disease-modifying treatment option that addresses the underlying pathophysiology of PV and reduces or eliminates the need for phlebotomy. “We look forward to initiating
Manouche
in
MPN Voice
11 months ago
Promising research is currently underway to use humanized bispecific single-domain antibodies
These antibodies engage different sub-types of T-lymphocytes to treat chronic
lymphocytic
leukemia
/small
lymphocytic
leukemia
CLL/SLL.
These antibodies engage different sub-types of T-lymphocytes to treat chronic
lymphocytic
leukemia
/small
lymphocytic
leukemia
CLL/SLL.
spi3
in
CLL Support
2 years ago
Treatment for life?
Hello. First time posting here. Diagnosed with CLL in July by flow test and Fish test. Although still technically in lymphocytosis. My chart says diagnosis: CLL. During the discussion in July my Dr told me of things they will be keeping an eye on. Then he said he won't discuss particular treatment plans
Hello. First time posting here. Diagnosed with CLL in July by flow test and Fish test. Although still technically in lymphocytosis. My chart says diagnosis: CLL. During the discussion in July my Dr told me of things they will be keeping an eye on. Then he said he won't discuss particular treatment plans
Quiltingone
in
CLL Support
8 months ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
tasquinimod in myelofibrosis (MF)
»The data showed that treatment with this drug results in normal blood counts, reduction of fibrosis in the bone marrow and normalization of spleen size in this mouse model. That suggests that tasquinimod can act as a disease modifying agent in MF » « The now planned study will investigate tasquinimod
»The data showed that treatment with this drug results in normal blood counts, reduction of fibrosis in the bone marrow and normalization of spleen size in this mouse model. That suggests that tasquinimod can act as a disease modifying agent in MF » « The now planned study will investigate tasquinimod
Manouche
in
MPN Voice
11 months ago
Jakafi + Grapefruit
Just came across this warning on Drugs.com. I had never seen before. Have those of you on Jakafi (ruxolitinib) seen this warning?
ruxolitinib food Applies to: Jakafi (ruxolitinib)
Do not consume grapefruit or grapefruit juice during treatment with ruxolitinib unless directed otherwise by
Just came across this warning on Drugs.com. I had never seen before. Have those of you on Jakafi (ruxolitinib) seen this warning?
ruxolitinib food Applies to: Jakafi (ruxolitinib)
Do not consume grapefruit or grapefruit juice during treatment with ruxolitinib unless directed otherwise by
hunter5582
in
MPN Voice
11 months ago
FDA APPROVAL FOR ZANUBRUTINIB
Here is the article: https://www.dana-farber.org/newsroom/news-releases/2023/dana-farber-led-study-leads-to-fda-approval-for-next-generation-drug-in-relapsed-chronic-
lymphocytic
-
leukemia
/ Carl
Here is the article: https://www.dana-farber.org/newsroom/news-releases/2023/dana-farber-led-study-leads-to-fda-approval-for-next-generation-drug-in-relapsed-chronic-
lymphocytic
-
leukemia
/ Carl
wizzard166
in
CLL Support
1 year ago
Chronic lymphocytic leukemia treatment algorithm 2022
Chronic
lymphocytic
leukemia
treatment algorithm 2022. Blood Cancer J. 12, 161 (2022). https://doi.org/10.1038/s41408-022-00756-9 Note: not all of the therapies recommended in this algorithm are available to patients in all places.
Chronic
lymphocytic
leukemia
treatment algorithm 2022. Blood Cancer J. 12, 161 (2022). https://doi.org/10.1038/s41408-022-00756-9 Note: not all of the therapies recommended in this algorithm are available to patients in all places.
CLLerinOz
Administrator
in
CLL Support
2 years ago
ASH 2022 | Key highlights in CLL: clinical trial updates combination therapies novel BTKis Lindsey Roeker and Matthew Davids • 10 Dec 2022
leukemia
(CLL) is constantly evolving, with novel Bruton’s tyrosine kinase (BTK) inhibitors transforming the field.
leukemia
(CLL) is constantly evolving, with novel Bruton’s tyrosine kinase (BTK) inhibitors transforming the field.
lankisterguy
Volunteer
in
CLL Support
1 year ago
AI searches- be careful!
result: "Yes, chronic
lymphocytic
leukemia
(CLL) may develop heart conditions as well. Over half of people with CLL treated with Imbruvica (ibrutinib) may develop atrial fibrillation (AFib). During AFib, the heart beats irregularly.
result: "Yes, chronic
lymphocytic
leukemia
(CLL) may develop heart conditions as well. Over half of people with CLL treated with Imbruvica (ibrutinib) may develop atrial fibrillation (AFib). During AFib, the heart beats irregularly.
Rico49
in
CLL Support
1 year ago
Pain in the spleen/splenomegaly
Hello, maybe someone has an idea. After 5 years w&w my spleen has now enlarged (splenomegaly). I've also been having pain on my left side for a few days now. Are there any natural or herbal ways I can support my spleen? Because I don't want to have a spleen removed. I don't take any other medicine,
Hello, maybe someone has an idea. After 5 years w&w my spleen has now enlarged (splenomegaly). I've also been having pain on my left side for a few days now. Are there any natural or herbal ways I can support my spleen? Because I don't want to have a spleen removed. I don't take any other medicine,
Omaschnabel
in
CLL Support
8 months ago
"Three-drug combination highly effective in patients with high-risk forms of chronic lymphocytic leukemia"
Three-drug combination highly effective in patients with high-risk forms of chronic
lymphocytic
leukemia
- https://www.news-medical.net/news/20221212/Three-drug-combination-highly-effective-in-patients-with-high-risk-forms-of-chronic-lymphocytic-leukemia.aspx - small USA trial (68) with acalabrutinib
Three-drug combination highly effective in patients with high-risk forms of chronic
lymphocytic
leukemia
- https://www.news-medical.net/news/20221212/Three-drug-combination-highly-effective-in-patients-with-high-risk-forms-of-chronic-lymphocytic-leukemia.aspx - small USA trial (68) with acalabrutinib
JIDD
in
CLL Support
2 years ago
Relapsed CLL: New Approaches Prolong Survival
Credit to Medscape NEW YORK – Most patients with chronic
lymphocytic
leukemia
(CLL) who relapse after treatment with a single agent Bruton's tyrosine kinase (BTK) inhibitor have one of several high-risk characteristics, including complex karyotype, 17p-chromosome deletion, or a TP53 mutation.
Credit to Medscape NEW YORK – Most patients with chronic
lymphocytic
leukemia
(CLL) who relapse after treatment with a single agent Bruton's tyrosine kinase (BTK) inhibitor have one of several high-risk characteristics, including complex karyotype, 17p-chromosome deletion, or a TP53 mutation.
Jm954
Administrator
in
CLL Support
1 year ago
Efficacy and safety of new‑generation BTKis (primarily acalabrutinib and zanubrutinib) in CLL/SLL: a systematic review and meta‑analysis
[/i] The full study title is
Efficacy and safety of new‑generation Bruton tyrosine kinase inhibitors in chronic
leukemia
/small
lymphocytic
lymphoma: a systematic review and meta‑analysis The authors are from the Department of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital
[/i] The full study title is
Efficacy and safety of new‑generation Bruton tyrosine kinase inhibitors in chronic
leukemia
/small
lymphocytic
lymphoma: a systematic review and meta‑analysis The authors are from the Department of Neuro-Oncology, Cancer Center, Beijing Tiantan Hospital
AussieNeil
Partner
in
CLL Support
8 months ago
Jak2/tet2 mutation
Hello this is Ben from VA! I was diagnosed with MPN last year and use Besremi every 2 weeks. I have jak2/tet2 mutations which makes me feel confused and scared since the majority of PVs only have jak2(or other so-called driver mutations). I read a lot online and it seems tet2 is not the worst thing
Hello this is Ben from VA! I was diagnosed with MPN last year and use Besremi every 2 weeks. I have jak2/tet2 mutations which makes me feel confused and scared since the majority of PVs only have jak2(or other so-called driver mutations). I read a lot online and it seems tet2 is not the worst thing
Ben2022
in
MPN Voice
11 months ago
Richters Transformation
I recently informed here that after nine therapy free years since 2014 (FCR) my CLL bounced back in 10/2022 with an DLBCL and a suspicion of Richters. Biopsy and Lab tests predicted that. Therefore I was immediately treated with R-CHOP 14 CI Therapy first in Hospital one week and then within the ambulance
I recently informed here that after nine therapy free years since 2014 (FCR) my CLL bounced back in 10/2022 with an DLBCL and a suspicion of Richters. Biopsy and Lab tests predicted that. Therefore I was immediately treated with R-CHOP 14 CI Therapy first in Hospital one week and then within the ambulance
seoul1949
in
CLL Support
9 months ago
Research Evaluating Risk of Richter Syndrome
Abstract is as follows: "Complex karyotype (CK) at chronic
lymphocytic
leukemia
(CLL) diagnosis is a negative biomarker of adverse outcome.
Abstract is as follows: "Complex karyotype (CK) at chronic
lymphocytic
leukemia
(CLL) diagnosis is a negative biomarker of adverse outcome.
jonathan7176
in
CLL Support
1 year ago
Epipen - Serious Nut Allergy
EpiPen - Serious Nut Allergy Good afternoon, My daughter got tested today at Preston Hospital, she tested positive for all types of nuts and was told she has Serious Nut Allergy which is Life Threatening without the Use of an Injectable EpiPen. My daughter was given one today at Hospital. Her Question
EpiPen - Serious Nut Allergy Good afternoon, My daughter got tested today at Preston Hospital, she tested positive for all types of nuts and was told she has Serious Nut Allergy which is Life Threatening without the Use of an Injectable EpiPen. My daughter was given one today at Hospital. Her Question
Joseph260268
in
Lung Conditions Community Forum
11 months ago
Ruxolitinib
Hi all, I have PV and AB is high , around 81% , spleen size slightly increased but if I didn’t know I have PV I would think I am the healthiest person around as I have no symptoms. I was diagnosed end of 2018 but had it al least since 2015. I am considering taking a part in clinical trial for Ruxo and
Hi all, I have PV and AB is high , around 81% , spleen size slightly increased but if I didn’t know I have PV I would think I am the healthiest person around as I have no symptoms. I was diagnosed end of 2018 but had it al least since 2015. I am considering taking a part in clinical trial for Ruxo and
Ameliav
in
MPN Voice
11 months ago
flow cytometry is showing about 74% CLL involvement.
Is it likely that treatment might be needed in the near future? Husband is trisomy 12, TP53 negative. Mutated. He has splenomegaly, and enlarged nodes. Fish is in process. INTERPRETATION A phenotypically abnormal population with forward and right-angle scatter features of small lymphocytes constitutes
Is it likely that treatment might be needed in the near future? Husband is trisomy 12, TP53 negative. Mutated. He has splenomegaly, and enlarged nodes. Fish is in process. INTERPRETATION A phenotypically abnormal population with forward and right-angle scatter features of small lymphocytes constitutes
juniper1975
in
CLL Support
9 months ago
CLL and mRNA Vaccines
Just saw this abstract, which is one of the papers being presented at the Boston CLL conference: https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004157 I don't understand most of it, but this is one of the "Findings": [i]CLL patients and other immunocompromised populations
Just saw this abstract, which is one of the papers being presented at the Boston CLL conference: https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004157 I don't understand most of it, but this is one of the "Findings": [i]CLL patients and other immunocompromised populations
BWHR
in
CLL Support
9 months ago
1
...
11
12
13
...
100
Next page
10
20
30
40
50
60
70
80
90
100
Filter results
Clear filters
Posted in
All communities
CLL Support
1938 results
MPN Voice
786 results
Leukaemia CARE
168 results
View top 10 communities
Sort by
Most Relevant
Newest